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Abstract
The thermodynamic principles of complementary binding of DNA or
RNA strands are well known, thus the binding efficiency can be
calculated for a given sequence. However, when a two-stranded molecule
contains mismatches in the base pairs, e.g. a guanine opposite to thymine
base, traditional models like the nearest-neighbour model do not suffice.
The influence of the location of these mismatches on the binding
efficiency, in particular, is not well understood. Understanding the
binding behaviour of nucleotide strands is essential to the development
of applications that require efficient and highly exclusive binding to
specific sequences in RNA or DNA. Such an application is exon skipping,
a gene correction therapy to treat Duchenne muscular dystrophy. An
alternative model has recently been developed at Leiden University to
explain this mismatch location dependency. This study is aimed at
comparing its calculations with experimental results obtained by DNA
encapsulated silver nanocluster fluorimetry. This type of fluorimetry uses
a special labelling technique to relate the emitted intensity of various
bulk samples to the binding efficiency. Mismatches are introduced in
various locations, and the binding efficiency is measured to determine
the dependency on the mismatch location. The binding efficiency as a
function of the mismatch location shows a relation that resembles the
calculations by the model. Improvements of the method are suggested
based on the results, allowing for a valid evaluation of the model.
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To Hans Rochat, who lost his son Marc to Duchenne Muscular Dystrophy
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Chapter1
Introduction
1.1 Background
Duchenne muscular dystrophy (DMD) is a disease known for its slow pro-
gression and impact on a patient’s life. It disables the muscles’ ability to
repair, hence it leads to muscle failure that spreads over time. Eventually,
the heart and respiratory system lose their function, leading to an early
death, usually before 30 years of age [4].
DMD is caused by hereditary defects in the genome that code for the pro-
tein dystrophin. A person with DMD produces a dysfunctional version of
dystrophin. Proper dystrophin connects membranes inside muscle fibres
to prevent damage during contraction, such as rips [5].
Some treatments that are currently in development use the principle of
skipping the defects in the code during the process of gene expression.
This leads to a short version of dystrophin that in contrast to the mutated
DMD gene is still functional [Aartsma oldest and newest]. Many promis-
ing studies have been conducted using mice and cell cultures [6] and in
clinical trials, the method has been moderately successful [7].
This skipping mechanism can only perform effectively when it binds effi-
ciently and exclusively to the defect parts of the sequence. This exclusive-
ness is of high importance since various cell functions will be impaired
when similar but “healthy” sequences have their translation into proteins
altered. This requires a thorough understanding of the binding behaviour
of strands, especially those with nearly identical sequences. The ther-
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modynamic principles governing the hybridisation1 of complementary2
stands are reasonably well understood through sequence dependent mod-
els such as the nearest-neighbour (NN) model 3 [8–10]. In the case of the
DMD gene therapy mentioned previously, “healthy” sequences different
from the target do not match the binding site of the drug exactly. However,
binding can still occur when only some single bases are different, which
are called “mismatched” bases [11]. The knowledge of mismatched bind-
ing behaviour is not sufficiently comprehensive yet to prevent treatments
from affecting other sites securely [6, 12], providing a challenge for current
studies into nucleotide4 thermodynamics.
In recent studies, several important factors have been identified such as
the type of mismatched base pairs, the type of strand configuration, i.e.
DNA/RNA, DNA/DNA or RNA/RNA5 and the hybridisation technique:
surface or solution and individual strands or bulk [13, 14]. It has been
suggested that the location of a mismatch in the sequence is a dominant
factor hence this influence is studied at Leiden University and in this BSc
research [13, 15, 16]
1.2 Goal
This study aims at developing a better quantitative understanding of nu-
cleotide binding for short duplexes with mismatches in their base pairs. In
particular, the binding efficiency dependency on the location of the mis-
matches in the sequence is of interest. This dependency can be obtained
from models, however, these still require their validity to be evaluated
experimentally. Using Ag-DNA encapsulated nanocluster fluorimetry, ex-
perimental results can be compared to the relation calculated by a model
developed at Leiden University in order to improve it. This is likely to
1Hybridisation is the binding of single strands that form a double stranded complex
(a duplex), which occurs at a sufficiently low temperature
2Able to form a perfectly matching double-stranded structure with the opposite nu-
cleotide strand.
3A model to calculate the binding energy of a strand by using sequence dependent
parameters, one for each nucleobase and its adjacent base. The traditional version of
this model can only be applied to perfectly matching strands and that is the only well
established one.
4The basic building block of nucleic acids, such as DNA and RNA. It is an organic
compound made up of nitrogenous base, a sugar, and a phosphate group. An elaboration
can be found in Acronyms and definitions.
5Here “/” means “bound opposite to”
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contribute to the development of treatments of DMD at the LUMC.
1.3 Approach
To obtain the binding efficiency for each mismatch location in a sequence,
experiments are conducted using specifically designed DNA strands that
are (near) complementary to a DNA excerpt of the DMD gene. These
strands are identical, except for a single altered base that will form a mis-
match with the DMD gene excerpt. The binding efficiency is determined
using samples in which the location of this mismatch in the sequence is
different for each sample. The binding efficiency for each strand is ob-
tained by measuring the emission spectrum of an Ag-DNA probe. The
binding efficiency is related to the emitted intensity through the strong
dependence of the optical properties of the Ag-DNA probe to its DNA en-
vironment. This property is explained in Theory 2.4. Since studies into this
binding behaviour commonly use aggressive dyes and synthetic binding
surfaces such as microarrays. Hence the approach of this BSc research is
in principle less subject to undesired effects on the binding efficiency and
reflects physiological conditions better. Moreover, it is cheaper, simple
and the experiments can be performed in a shorter amount of time. With
these measurements, the mismatch location dependency can be graphed
and compared the calculated result generated by the model.
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Chapter2
Theory
2.1 Application to gene correction therapy for Duchenne
muscular dystrophy
2.1.1 DMD and its cause
An improved understanding of the binding behaviour of DNA duplexes1
containing mismatches2 can substantially contribute to a wide range of
medical applications. In particular, it can be applied to a gene correction
therapy, that potentially provides a treatment for Duchenne muscular dys-
trophy (DMD). The therapy is based on targeted binding of the active drug
components to specific sequences in pre-mRNA, thus requiring efficient
and highly exclusive binding [17] .
DMD is a hereditary muscular disease that causes a major decrease in a pa-
tient’s mobility and drastically lowers the life expectancy [18, 19]. It affects
roughly 1 in 5000 live male births worldwide [20]. The muscles degrade by
a deficit of functioning dystrophin, which is a protein that prevents dam-
age to the muscular tissue. It serves as an “anchor” connecting elements
moving relative to each other in the muscle: the actin cytoskeleton and the
myocyte membrane [21]. This causes the muscles to lose functionality and
they are replaced by fat tissue consequently. Several genetic defects such
as deletions and duplications in the dystrophin gene are responsible for
1A DNA structure consisting of two strands bound opposite of each other
2A mismatch in this context means a change in the pattern of the bond locations in-
hibiting the formation of a base pair, e.g. a G base opposite of a T base instead of the
fitting C base.
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producing truncated proteins that fail to form this connection [5, 6, 22].
An example of a genetic defect that causes DMD is a mutation in a sec-
tion named exon 51. An exon is a section of the pre-mRNA sequence that
is processed into the mRNA. Therefore, an exon will be translated into a
protein. Introns are sections of pre-mRNA that are skipped in this process,
contrary to exons. This selective skipping process is called “splicing” [23].
Due to mutations in the DMD gene, exon 51 does not appear in the mRNA
after splicing, leading to a frameshift in the mRNA sequence. This shift in
the reading frame is not a multiple of three bases, which is the length of a
codon 3. Therefore other groups of three bases are falsely interpreted as the
codons that are to be translated into proteins. Thus, this shift means that
the reading is disrupted, resulting in abnormal codons being translated
[24]. Consequently, one codon is misread as stop-codon and the produced
dystrophin protein is truncated, thus not functional. The corresponding
mRNA strand is out-of-frame. [25].
2.1.2 Exon skipping: a treatment for DMD
Skipping this exon introduces a further shift that makes the total shift a
multiple of three. This is again in-frame since codons consist of three
bases. Although causing the protein to be shorter, this will not lead to
a truncated protein and therefore it is functional nevertheless. As a re-
sult, the effect of the dystrophy is significantly decreased. Instead, a form
of Becker muscular dystrophy (BMD) or even the absence of dystrophy
symptoms is achieved. [24, 25]. BMD is a disease similar to DMD that is
far less severe than DMD, consequently, BMD patients have far higher life
expectancy than those with DMD[22].
To force the skipping of normal exons such as exon 51, antisense oligonu-
cleotides (AONs) can be used. These are synthetic single strands with
nucleobases that “hide” the exon to which they bind during the splicing
process [26]. Furthermore, the skipping of exon 51 can restore the reading
frame in more mutation cases: 13 % of deletions can be treated by target-
ing this exon, more than other exons [6]. Figure 2.1 displays a schematic
of an exon skipping technique from E.M Conner et al. [1]
3A codon is a group of three nucleobases coding for one amino acid, which is the
constituent of a protein
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Figure 2.1: An example of the principle of the exon skipping treatment [1]
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Various other treatments for DMD are studied and applied as well. How-
ever, the advantage of exon skipping is its ability to halt the progression
of the disease. The common non-genetic therapies, such as the use of
steroids, only help to maintain muscle functionality for limited periods.
Other approaches that instead of exon skipping or non-genetic treatments
edit the DMD gene were found to be inefficient at the current stage of de-
velopment. The exon skipping with AONs has been more successful as
well. Additionally, gene editing methods, such as CRISPR/Cas9 perma-
nently modify the genetic material, in contrast to exon skipping. There-
fore these techniques are subject to ethical objections and safety concerns
[6, 12, 27].
2.2 Nucleotide hybridization: the binding behaviour
of complementary strands
2.2.1 Bonding structure
The hybridisation of nucleotide strands is a crucial function inside living
cells that allows for gene expression, which is a vital mechanism in the hu-
man body. Various diseases and treatments involve altered gene expres-
sion or binding to specific sites on DNA and RNA [26]. Nucleotide strands
form stable duplexes by the forces present in the hydrogen bonds between
opposite nucleobases (cytosine, guanine, adenine, thymine or uracil) [28].
A hydrogen bond is a noncovalent bond between a molecule and a hy-
drogen atom from another molecule in which the rest of the latter is more
electronegative than the hydrogen. [29]. Longer duplexes contain more
bases, thus more bonds and are therefore generally stronger. Additionally,
a duplex containing more guanine-cytosine (GC) pairs than one of equal
length is generally stronger since a Guanine-Cytosine (GC) pair is bound
by three hydrogen bonds instead of an adenine-thymine (AT) pair, which
consists of only two [30]. The hybridisation can be quantified by bind-
ing strength, which is a force or thermodynamic binding quantities, i.e.
free binding (Gibbs) energy, entropy and enthalpy. Additionally the melt-
ing temperatureTM, which is the minimum temperature at which 50% of
strands are not hybridised, [31] or the binding efficiency, i.e. the percent-
age of strands that form a duplex when single strands are mixed in bulk
are useful quantities. In this study, that last quantity is used.
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Figure 2.2: Nearest neighbour method: calculation of the free energy of a duplex
[2]
2.2.2 Nearest-neighbour method
As the binding energy of duplexes appears to be highly dependent on their
structure, this induces the development of computational models to pre-
dict the binding energies using the sequence of a complementary strand.
Indeed such a model has been developed which is well-known for its ac-
curacy: the nearest-neighbour (NN) method [32]. The principle of this
method is the summation of free energy elements ΔG corresponding to
segments of the strand to obtain its total free binding energy. These seg-
ments consist of a base pair and the neighbouring pair e.g. GC opposite
to CG in this explanatory figure 2.2 [2]. An initial free energy element is
required to account for the terminals since they have only one neighbour.
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2.3 The binding behaviour of mismatched strands
2.3.1 Background
The traditional NN method, however, only applies to complementary strands
and duplexes can contain mismatches, e.g. a guanine opposite of a thymine
base, with the different hydrogen bond patterns inhibiting the formation
of a base pair [8]. The study of the binding behaviour of these duplexes is
currently at an early stage and models based on the sequence have been
unable to predict the binding energies of mismatched duplexes as accu-
rately as complementary strands.
Models, calculations or databases that have been developed to predict the
effect of mismatches often aim to contribute highly in depth to the the-
ory of the binding behaviour [33]. Although providing a thorough un-
derstanding, a more general approach is believed to improve the applica-
tion with a higher rate. Said in depth studies involve mainly NN param-
eter corrections for mismatches [2, 8, 34–36] or the binding energies corre-
sponding to various DNA structure configurations caused by mismatches
[10, 11, 37–39]. Applications request insight into the explicit effects of mis-
matches on the binding efficiency of strands in bulk instead [40].
Most studies into general sequence-dependencies of the binding efficiency
focus on experimental findings or models for hybridisation in or on other
media than those similar to human cell environments, e.g. microarrays
[33, 41, 42]. Furthermore, there are many studies aimed at the design of
highly mismatch intolerant oligonucleotides or sequence detectors [17, 43–
47]. These tend to rely on ”massive” machine learning, e.g. neural net-
works, or trial-and-error [48].
They have contributed to applications to the extent that clinical trials with
AONs for DMD treatments were moderately successful [7]. Nevertheless,
these programs or large databases are not suitable for proper predictions
of binding efficiency due to their analytic nature and therefore do not sig-
nificantly improve the (qualitative) theoretical understanding. The author
of this BSc thesis believes this is essential for the AON-methods ever to
lead to a real cure for DMD since a substantial prolongation of life has not
yet been achieved [12].
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2.3.2 Location dependency
The location of a mismatch in a sequence is suggested to be an important
factor in the binding efficiency [14, 49, 50], although this has often been
denied or neglected before [36, 38]. For a single mismatch, which means
only one base alteration per strand, this dependency seems to be dominant
over the type of nucleobases at a mismatch, e.g. a guanine base opposite
of a thymine base [13, 15, 16]. However, there is no clear consensus on this
[14, 51] as the type dependency is complex, and more sensitive to other
influencing factors [52].
Generally, mismatches positioned in the centre of the sequence tend to re-
sult in a lower binding efficiency, while positions closer to the 3’ or 5’ end
lead to higher efficiencies for strands roughly between 15 and 20 bases
long [13–15, 53]. Other studies that focused on the specificity of binding,
i.e. the tendency of a strand to not bind with mismatched targets, indi-
cate the same result. [52, 54]. Additionally, in some of these studies, the
relation was not found by the design of strands with single base changes
bound to one target sequence. Instead, a method was used in which vari-
ous different strands were mixed and those forming a stable configuration
were categorised by their sequence to count the mismatched strands per
position.
In contrast, strands of roughly 20 to 25 bases often increase in binding ef-
ficiency when the mismatch is positioned in the middle as well as close to
the ends. It decreases in between, resulting in the W-shape that can clearly
be seen in the result from this study: [55]. This has also been found in un-
published work available to the author of this BSc thesis: [56]. The same
effect, however less clear, is mentioned in these papers: [14, 54]. Even
longer sequences are less affected by a single mismatch since there are
many binding sites available to form stable bonds, making them less sen-
sitive to the position of the mismatch [54].
Most studies attribute these position relations to effects caused by the
DNA being surface-bound, which indeed has an influence on the binding
efficiency [8, 14, 52]. Furthermore, the labels that are used to distinguish
bound strands from unbound ones can affect the binding as well, espe-
cially aggressive dyes [45, 57, 58]. However, the efficiency increase close
to the ends has been observed or suggested in solution based research as
well [49, 51, 56]. These apparent similarities suggest that these studies are
useful in physiological context, although the methods used can cause a
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strong deviation from in vivo binding behaviour. They can direct the aim
of this research topic, nevertheless repeating them with dye-less solution
based experiments is required.
Models or theories that explain the effect of mismatches on the binding ef-
ficiency commonly do not incorporate the location dependency explicitly.
Moreover, there is little consensus between them and they are not consid-
ered generally valid [59]. Additionally many fail to explain or predict the
increased binding efficiency at central mismatch positions that appears in
longer strands, mentioned previously.
The approach of location dependent models varies, e.g. a position depen-
dent correction on the NN model [41, 60] or principal statistical thermo-
dynamics such as Langmuir [8, 13, 15, 53] or Sips [58, 61]. Some of these
models are purely based on experimental data, e.g. those introducing new
NN parameters, which may be problematic to generalise for any sequence
or environment. This, in combination with the focus on arrays and influ-
ence of dyes on the results on which these models are based, requests the
development of novel models.
2.3.3 The model used in this thesis
A model aiming to predict or explain the explicit effects on binding effi-
ciency as a function of the position of a single mismatch in a strand has
recently been developed at Leiden University. The work has not been
published yet (July 2017) and the author of this BSc thesis provides the
necessary information about the model in this work on the basis of com-
munication with its developers and this article draft: [56].
To avoid this complexity of effects on the secondary structure of the DNA,
the model used in this study treats the mismatches not as nucleotide ele-
ments, but as “gaps” in the strand instead. With this approach, the strand
is virtually divided into two sections: one on the left of the mismatch and
one on the right. These separate sequences are now essentially comple-
mentary, allowing one to apply the traditional NN model, which is more
accurate than mismatch models [9]. The complex behaviour of the mis-
matches is then introduced in a simplified way through a correction in the
energies, representing the average effect of a mismatch on DNA binding.
This allows for the explicit calculation the predicted binding efficiencies
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for any sequence to determine the generalised behaviour. This correction
includes the dominant influence of ”dangling ends”.
A dangling end means that a part of the strand does not form hydrogen
bonds with the target strand, while the rest of the strand does. The duplex
is partially ”unzipped” and one part ” dangles loosely” under Brownian
motion [37]. The longer the dangling part, the weaker the duplex and in
this model, its effect is linear with the mass of the dangling section. As
explained earlier, the longer a (section of) a strand, the more bonds can
be formed, and the more stable the duplex is. Therefore both statements
indicate that a sequence section can either be too short to bind or too long
to prevent unzipping, leading to a nonintuitive balance that explains the
complexity of the relationship that has been observed. In this model, the
position of the mismatch governs the various dangling end configurations
leading to large differences in binding efficiency for different positions.
The model calculates the total enthalpy change ∆H using two terms; one
corresponding to the sequence to the left of the mismatch and the other to
the one on the right. This limits the applicability of this calculation to non-
terminal mismatches, i.e. not at either end of the sequence, since only one
of the two halves exists when the mismatch is at a terminus. Each of these
enthalpy terms contains a term determined by the traditional NN method
minus a correction for the effect from the concatenation of the mismatch
and the rest of the sequence. In an equivalent manner, the total entropy
change ∆S is calculated. The total entropy and enthalpy changes are used
to predict the binding efficiency for a mismatched sequence. When this is
calculated for all positions, the position dependency can be obtained in a
format that is fitted to experimental results. The developers of the model
describe the used equations as follows:
“The changes in enthalpy (ΔH) and entropy (ΔS) upon the binding of two
DNA strands of length N can be determined from:
∆H = ∆h0 +
N
∑
i
∆hi (2.1)
∆S = ∆s0 +
N
∑
i
∆si (2.2)
using the previously determined energy changes from an individual base
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pair (∆hi,∆si) in the nearest neighbour model [9, 10]4. The melting tem-
perature, Tm, can then be determined from
Tm =
∆H
∆S + R ln(C)
+ 16.6 log(Na+) (2.3)
where C is the total concentration of oligonucleotides when both strands
are in equal numbers, and [Na+] the molar concentration of monovalent
cations in the solution.” The binding efficiency introduced as θ is expressed
in the following manner:
θ = 1− 2
1 +
√
1 + 8 exp(−χ) (2.4)
with
χ =
∆H
R
· ( 1
T
− 1
TM
) (2.5)
”
The enthalpy and entropy terms corresponding to the sections of the se-
quence left and right from the mismatch are
∆H′le f t/right = ∆Hle f t/right − JH(1− θle f t/right) (2.6)
and
∆S′le f t/right = ∆Sle f t/right − JS(1− θle f t/right) (2.7)
where JH and JS are the corrections for the separate sections being con-
nected with a mismatch. The binding probabilities of the separate sections,
derived from NN equations, are θ′le f t and θ
′
right. These are used as weights
for the energy terms in eq 2.6 and 2.7 in the calculation of the total energy
changes:
∆H = ∆H′le f tθ
′
le f t + ∆H
′
rightθ
′
right (2.8)
and
∆S = ∆S′le f tθ
′
le f t + ∆S
′
rightθ
′
right (2.9)
4The original reference numbers have been replaced by the ones corresponding to the
bibliography in this BSc thesis
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None of the models described in 2.3 are well-established and consequently
request various refinements. This requires effective and short experiments
to test their validity. An appropriate method that serves this purpose is
Ag-DNA encapsulated fluorimetry.
2.4 Ag-DNA encapsulated nanocluster fluorime-
try
When silver atoms are clustered on the nanoscale and excited by a monochro-
matic beam, they display a fluorescence with plasmonic properties [62].
These clusters quickly lose this property due to agglomeration into bulk
objects. This is prevented by encapsulating the strands in molecular struc-
tures like DNA. As a consequence, these molecules will determine the
shape of the cluster and therefore the optical properties that depend on
the aspect ratio of the nanocluster [62, 63]. When DNA is used, the fluores-
cence is photostable [64] and highly sequence (length) dependent [63–69].
Even a single base change in an encapsulating DNA structure shifts the
emission spectrum significantly, indicating a very high sensitivity to the
DNA structure [3, 70] which can be seen in figure 2.3. This sequence speci-
ficity provides opportunities for effective targeting of short ssDNA (single
strand DNA) [63] and is already applied in some studies [70–73].
Several encapsulation probes for silver with clear and distinct optical prop-
erties have been found in the last 20 years, however, the sequence depen-
dence is not well understood yet. Notwithstanding, Machine Learning
methods are promising tools to improve the insight into this behaviour
[74] and this publication attempts to explain the effect [75]. It has been
found that the clusters favour the adherence to G or C bases in general
[66, 76] and the emission spectrum shifts to higher wavelength range with
increasing sequence length [62, 69].
Furthermore, certain encapsulations cause the otherwise biocompatible
silver suitable for in vivo applications. This toxicity is even tuneable, thus
targeted medical applications are possible as well [63].
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Figure 2.3: Heat map of intensity for each excitation wavelength (horizontal) and
emission wavelength (vertical). When an adenine (A) base in the encapsulating
nucleotide structure (left) is altered to a cytosine (C) base (right), the fluorescence
changes significantly. The diagonal “line” is caused by scattering of the excitation
frequency into the emission measurement.[3]
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Chapter3
Methods
3.1 General
3.1.1 Probe-AON technique
This study used an Ag-DNA fluorescence technique to study the binding
sensitivity of mismatched strands. This requires a fluorescence behaviour
from the Ag-DNA that relates in a specific manner to the binding effi-
ciency, i.e. the intensity of the emission increases with increasing bind-
ing efficiency. Not all strands display this relation , therefore a specific
sequence is selected during the AON-testing experiments that clearly dis-
tinguishes the unbound and bound configuration through the measured
emitted intensity.
The used strands are concatenations of an Ag encapsulation strand and a
stand identical to an antisense oligonucleotide (AON) sequence. The Ag
encapsulation strand, called 19b-probe, is a short sequence that has been
shown to display a bright emission of the silver clusters [63, 69], which
is illustrated in the schematic in figure 3.1 and figure 3.2.The blue dashed
line in figure 3.2 corresponds to this strong fluorescence. In this study and
previous ones, it is found that its intensity is significantly lowered when
concatenated with AON-sequences [56] as seen in figure 3.1, with the cor-
responding spectrum as the black line in figure 3.2. Any fluorescence from
other sources will have only low intensity in the wavelength domain that
is measured in this experiment, as explained in Theory 2.4.
The AON-sequences are designed to bind to a target sequence: a 90 base
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Figure 3.1: Cartoon of Probe-AON technique to measure binding efficiency
through fluorescence intensity. The corresponding emission spectra can be seen
in figure 3.2. The AON measured here is not used in this research.
excerpt of exon no.51 of the pre-mRNA sequence1 that produces the pro-
tein dystrophin when expressed. This exon is of interest in research into
gene correction therapy for DMD [26], including studies in Leiden at the
LUMC. An elaboration on exons and AONs can be found in Theory 2.1.2.
When this target strand binds to the probe-AON strand, the AON part of
the strand cannot encapsulate the silver cluster, as its bases are already
bound to the targeted exon sequence. This leaves only the probe part
“free” to influence the optical properties of the cluster, resulting in a nearly
identical spectrum as emitted by the probe alone as seen in figures 3.13.2
(green line).
Using Ag-DNA in a solution to obtain the binding efficiency, a substantial
influence on the result is prevented that would be present when the more
common fluorescent dyes were used. In contrast to microarray studies, the
method is cheap and the experiments are short and simple. The manufac-
turing of the custom strands is done by an external company, and from
design to receiving the DNA took no longer than a week. In one session,
1The sequence can be found in 8.2
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Figure 3.2: Emission spectra corresponding to the Ag-DNA probe method in fig-
ure 3.1.
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roughly 10 samples can be prepared and measured, which takes roughly 6
hours for the author of this thesis and for experienced laboratory workers
at least a few hours due to waiting time. Six sessions are likely to produce
a sufficiently accurate result.
3.1.2 Procedures
3.1.2.1 Preparing samples
To measure the fluorescence intensities, the strands are sampled in bulk
according to the recipe specified in the Appendix: 8.3. The recipe for the
samples is based on what is known to produce a strong fluorescence from
the 19b-Probe. The solutions and samples are made in 1.5 mL microcen-
trifuge tubes using variable volume single channel pipettes. All chem-
icals are dissolved in nuclease-free water to protect the DNA material.
Sample preparation and measurement are performed in a HEPES-NaOH,
pH 7.4 buffer, representing conditions fairly close to physiological condi-
tions within the cell. The tubes are kept at 37 ◦C to resemble intracellu-
lar fluid and, after inserting all DNA, given 2 hours for hybridization to
take place. Afterwards, AgNO3 (99.9999%, Sigma Aldrich), containing the
silver atoms, is added, followed by NaBH4 (99%, Sigma Aldrich), which
neutralises the silver ions. During those last steps, the samples could not
be kept at the 37 ◦C, but samples were at room temperature for no longer
than 30 minutes during this research. After synthesis, the fluorescent sam-
ples are placed inside a Cary Eclipse fluorimeter (Varian) to obtain their
emission spectra.
3.1.2.2 Measurement
The samples were kept at 37 ◦C Celsius in the dark for half an hour be-
tween the addition of the reduction agent and measurement during the
AON-testing experiment and an hour during some of the mismatch ex-
periment sessions. A Peltier-element was used to keep the cuvette inside
of the fluorimeter at 37 ◦C as well. With the fluorimeter, the emission spec-
trum of each sample is measured at an excitation wavelength of 495 nm,
representing the excitation maximum of the used 19b-Probe [69]. In this
research, the emission was measured from 500 nm to 650 nm, with a step
size of 1 nm.
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3.1.2.3 Data processing
The resulting curves of the samples can be integrated over all emission
wavelengths to obtain their total emission. The emission spectrum is near-
Gaussian, the wavelength step size is small and only the intensity of the
samples relative to each other is relevant in this research. Therefore the
total emission is obtained by summing over the emission spectrum, to ap-
proximate the integral as a Riemann sum, which simplifies data process-
ing. Due to scattering of the excitation from the measurement device, for
wavelengths close to the excitation, the spectra do not display the emission
accurately. Therefore, the summation starts at 565 nm instead, the known
emission maximum of the 19b-probe. The symmetry of the near-Gaussian
shape allows the higher wavelength-half of the spectrum to represent the
entire spectrum.
3.2 AON-testing
The purpose of this experiment is selecting one AON-sequence from 5 test
sequences with an emitted intensity that increases with binding efficiency,
which is required in the next stage of this study. For this purpose, the
emission intensity of several complementary duplexes of the sequence is
compared to their single strand configuration. Since in the first case, the
strands bind optimally and the latter cannot bind because there is no com-
plementary strand, a maximum difference in intensity is expected. The
sequences are referred to as Test-AON1 to Test-AON5. Although their
name suggests that these are only AON-sequences, all of them contain the
19b probe sequence on the 5’ end followed by the actual AON-sequence,
so the 3’ end will always be “dangling” to encapsulate the silver cluster.
Also, note that these are not actual AONs, but DNA strands with iden-
tical nucleobase sequences, unlike AON strands which typically consist
of modified RNA. Two sets of five samples are produced for the five test
sequences. In one of those sets, the complementary strand, the exon se-
quence, is added to accomplish the bound configuration. To the other one,
the same volume, this time of nuclease-free water, is added instead of the
complementary DNA solution. Consequently, no DNA-binding occurs in
those tubes. For each sample, the summed intensity of the test sequence
with exon is compared to the same sequence with only water. The ratio
between these can be calculated for each AON in order to select the AON
with maximum intensity in bound configuration and minimum intensity
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in unbound configuration. In many cases, this can already be concluded
from the emission spectra by eye.
3.3 Mismatch experiment
With the AON-sequence selected based on the results from AON-testing,
another set of measurement sessions is performed. The purpose of these
experiments is to obtain the mismatch location dependency of the bind-
ing efficiency. This is achieved by altering one base of the AON-sequence
per sample and varying the position of this base change. In doing so,
samples are produced for each possible location of the altered base, thus
the set of AON/Exon2 complexes is mismatched on 20 positions in total.
Each sample, thus each mismatch location, is measured to get the intensity
per location. The exact base changes can be found in the sequence table
in the Appendix 8.2. As explained in the Discussion of the AON-testing:
5.2, AON4 was chosen for the mismatch experiments. During most of the
sessions, the order of measurement and addition steps during the sample
preparation are randomised to minimise time-dependent influences on the
result.
In order to compare the results from different sessions and to relate the in-
tensity to the binding efficiency, the intensities are normalised by the (av-
erage) intensity at the end of the strand, i.e. location 20 or 19 in sessions
during which location 20 is not measured. Ideally, one would normalise
with the complementary strand, however, this was not done because those
results proved unreliable, as explained further in the Discussion. In the fi-
nal result, all intensities are normalised by the average of location 20 and
are averaged per mismatch. The standard deviation corresponding to the
data per mismatch location is also obtained from these normalised inten-
sities, to represent the error in the measurement.
3.4 Fitting model with parameters
The prediction by the model developed at Leiden University described in
the Theory, 2.3.3, is fitted to the experimental line of the mismatch loca-
2The slash means “bound to” in biochemical convention, so “A/B” would be strand
“A” forming base pairs with the opposite strand “B”
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tion relation. There are two parameters to set corresponding to the JH and
JS terms in equations 2.6 and 2.7. These are set manually for the best fit
under the restriction that they are small relative to ∆S and ∆H, allowing
for the linear corrections JH and JS to be appropriate. In these results, they
represent less than 1% of the total energetic change, meaning this is the
case.
3.5 Control experiment: determining error in sam-
ple preparation
Before an accurate result can be obtained from the AON-testing and the
mismatch experiment, the error due to the inconsistent preparation of
samples, e.g. imprecise pipetting, should be limited. To determine this
error, five samples of only the 19b-probe, or GS4T, are measurement. Be-
cause no AONs and target strands are included, the volume of buffer used
is 80 µl and the 20 µl DNA solution is added. Like before, the intensities
are obtained through a Riemann sum and the standard deviation divided
by the average intensity is calculated to determine the error.
3.6 Control experiment: checking fluorescence sta-
bility
Since problems arose considering the precision of the measurement, the
stability of the intensity from several samples is evaluated. During the
time required for the silver to be fully neutralised by the reductor, the
emission spectrum from one sample is obtained every 30 seconds. Like
before, each spectrum half is summed to obtain the intensity per time in-
terval and the intensity through time is graphed. The result is fitted with a
double exponential to check whether the curve levels to a constant value,
which would indicate stability.
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Results
The raw data from the fluorimeter contains the measured intensity in ar-
bitrary units (a.u) for each emission wavelength in nm, with a step size of
1 nm.
4.1 AON-testing
4.1.1 Measurements from the first session
To identify which AON-sequences would be suitable to use in our mis-
match experiments, during two sessions the test-AONs were measured.
As explained in Methods 3.2, for each test-AON the spectrum is mea-
sured in bound and unbound configuration, to compare these states. In
the bound configuration, the binding of the AON-sequence to the 90b-
target is efficient and the intensity of the spectrum should be high. In the
unbound configuration, the target is replaced by nuclease-free water, so
the entire test-AON can influence the silver fluorescence. From the AON
design, a far lower intensity is desired and expected.
In figure 4.1 the spectra from the test-AONs, measured during the first
measurement session, are graphed. The intensity of test-AON5 with tar-
get exon (red solid line) is clearly higher than without (red dashed), with
the unbound sample producing a background fluorescence less than 3%
of the signal when binding occurs. For test-AON4, this holds as well, al-
though the difference between the bound configuration (black solid line)
and unbound (black dashed line) is smaller than for AON5, the back-
ground fluorescence from the unbound sample being about 14% of the
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Figure 4.1: The emission spectra from the probe-AON strands, measured with
the added exon target in one sample (bound configuration) and only nuclear-
free water added to the other (unbound). These were measured during the first
session.
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highest measured signal. AON2 and AON3 show a negligible difference
between their two configurations: they overlap for many wavelengths.
AON1 even shows an opposite behaviour: the intensity in bound con-
figuration (cyan solid line) is clearly lower than in unbound configura-
tion (cyan dashed line). All spectra are approximately Gaussian and are
peaked at roughly 565 nm, in agreement with the expected fluorescence
of the 19b-probe. The peaks from the two lowest curves: unbound AON4
and AON5 1are slightly shifted, and seem to have a peak at roughly 570
nm.
4.1.2 Measurements from the second session
To confirm our results, the experiment was repeated, as shown in figure
4.2. Generally, the same relations between the unbound and bound states
can be seen in this repetition. An exception being that test-AON2 also
shows a higher emission intensity in the unbound state (dashed deep blue
line), than when it is bound (deep blue line). Again the curves are near-
Gaussian and have the same peak wavelengths as those from the first ses-
sion.
1Although challenging to see for AON5 in this figure
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Figure 4.2: The emission spectra from the probe-AON strands, measured with
the added exon target in one sample (bound configuration) and only nuclear-free
water added to the other (unbound). These were measured during the second
session.
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Figure 4.3: The sensitivity of binding efficiency to the location of the single mis-
match expressed as the related intensity. This is normalised by the value of mis-
match (mm) position 20, here plotted as the black line. In red, the averaged ex-
perimental result and in blue, the model fit.
4.2 Mismatch experiments
Single-base mismatches were introduced into the sequence in all possible
locations, and the fluorescence intensities were measured after hybridiza-
tion and silver cluster synthesis. In doing so, we measured the mismatch
dependency of the hybridization of our AON sequence, test-AON4. In
figure 4.3 the model prediction is plotted in blue with the experimentally
found line in red. The normalised intensities represent the total emission
from the samples, obtained from the Riemann summation of the spectra.
The model predictions are the result of the calculations presented in The-
ory 2.3.3. Using the Ag-DNA probe, the measured fluorescence intensity
is positively related to the number of bound strands, allowing us to use it
as a measure of the binding efficiency. The lines between points are plot-
ted to simplify the interpretation, however, the results are discrete, there
is no intensity or binding efficiency between the integers of the mismatch
position.
The intensities were normalised by the average intensity of mismatch 20
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for reasons explained in the Discussion 5.3. For clarity, this intensity is
plotted as a black line. The points on the red line are averages of the nor-
malised data from 9 measurement sessions. The error bars depict the stan-
dard deviation of the data sets. The binding efficiency for a mismatch
at position 1 is not calculated by the model, and produces unpredictable
results due to the proximity of the mismatch to the silver cluster, and is
therefore excluded from the measurement.
For most locations, the measured intensities are below the normalisation
meaning the mismatch affects the binding of the strands negatively, as ex-
pected. A notable exception is location 2, which is likely to also be the
result of the proximity of the mismatch to the silver cluster. When ap-
proaching the terminals, the calculated curve increases to 1 much more
rapidly than measured behaviour. In the middle range, in particular, be-
tween locations 7 and 12, both model and experimental results display
similar peaks and dips. Most average intensities from the experimental
data are around 0.5, with a maximum at position 2 of approximately 1.5
and a minimum at position 8 of approximately 0.35. At the terminals, the
error is especially large, roughly 0.7 for positions 2 and 19 and the error is
not less than 0.2 for any location.
The model is the result of exact calculation and does not indicate uncer-
tainties. Its predicted binding efficiencies range from approximately 0.17
at position 8 to 1 at position 19.
4.3 Control experiment: checking fluorescence sta-
bility
From several measurement sessions, the intensity over time is graphed
in figure 4.4 to determine if it has been a constant at the start of the ses-
sion. The measured behaviour is characterised by an exponential function
which stabilises to a constant after a certain time.
In this figure, it is clear that the 19b-probe (green) displays this behaviour,
showing fair stability after approximately 30 minutes. However, when the
AON is added to the probe sequence (black), or when including a mis-
match (blue), stability was not reached within anywhere close to the same
timeframe. Both intensities from the probe-AON strand and mismatched
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Figure 4.4: (Rescaled) intensity development over time from three samples and
the exponential fit to these curves.
strand are not constant during the time of the measurement, respectively
from 28 minutes on and 56 minutes on, and the behaviour is clearly differ-
ent for the two cases as well. The curves have been rescaled in the vertical
direction to be able to compare them in one view, which preserves their
development.
4.4 Control experiment: determining error in sam-
ple preparation
In figure 4.5 the spectra are graphed from five samples containing the 19b-
probe that were prepared with identical content and conditions to deter-
mine the human error involved in their preparation. The overall intensity
of these spectra is calculated and the standard deviation of these numbers
is determined. The standard deviation normalised by the average of the
intensity was found to be 13.37%, thus the error corresponding to human
imperfections in sample preparation is approximately 13%.
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Figure 4.5: The spectra from five samples containing the prepared 19b-probe
GS4T prepared according to the same recipe. From high to low: a purple, an
orange, a blue, a green and a yellow curve.
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Discussion
5.1 Inaccuracy in the Ag-DNA probe method
When bases from the target bind to the AON-strand, the resulting struc-
ture can have various configurations that vary in binding energy. This
means that ”bound” and ”unbound” are not the only states of hybridisa-
tion [38]. The Ag-DNA probe method is used to relate emitted intensity
to the binding efficiency, however, it can fail to distinguish configurations
that are only partially bound, i.e. ones with ”dangling ends”. This term is
explained in Theory 2.3.3.
Dangling ends can occur on one of the sides next to the mismatch and if the
probe-end, i.e. the 5’ end, is dangling, it is likely to affect the encapsulation
in a manner that lowers the emission in the measured wavelength range.
This means that, in particular when a large part of the strand close to the
cluster is dangling, it will appear as ’unbound’ in the measurement, even
though it is partially bound. Especially when the mismatch is close to or
at the 5’ end, the effect of a short dangling part at this end is highly unpre-
dictable. Furthermore, the 3’ end may dangle in various degrees, whilst
not affecting the encapsulation on the 5’ end, leading to similar emitted
intensities that fail to distinguish these various weak bonds from a non-
dangling 3’ end.
Consequently, the probe-AON method is less sensitive to binding weak-
nesses on the 3’ side of the mismatch, when, as in our experiments, the
probe is attached to the 5’ end. Therefore, it is recommended for future
studies to design strands with the probe on the 3’ end as well.
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In the context of the application of actual AONs, considering duplexes
with dangling ends as bound is less problematic. This is reasonable since
exon skipping as described in Theory 2.1.2 still functions when only part
of the AON is connected to its target. Thus it can be debated whether the
results found in this study corresponds even better to the effectiveness of
AONs in treatments than to the binding efficiency of the entire strand.
5.2 AON-testing
5.2.1 Evaluation of usability
From the spectra in figures ?? and ??, it is clear that test-AON4 and test-
AON5 cause the probe to emit a far higher intensity when bound to their
complementary parts of the target exon, which is required to accurately
relate the binding efficiency to a measured intensity. A reverse relation,
which AON1 displays, is not linear since the low-intensity region is noisy,
contrary to the positive relation. Therefore the method is more accurate
when AON4 or AON5 is used.
5.2.2 Hypothesis on spectral differences
The difference between the AON-designs’ spectra can be attributed solely
to the sequences since all samples were prepared and measured under the
same conditions. The author of this thesis suggests that the encapsulation
affinities of AONs 1,2 and 3 were lower. Thus this resulted in the ordinary
probe encapsulation even without the exon, and the dangling AON-parts
of the strands did not interfere. Generally, the number of G or C bases and
the length are a factor in this affinity [62, 66, 69, 76], however, based on the
used sequences in 8.2, neither of these could have caused the differences.
It is not plausible that the problems considering the fluorescence instabil-
ity affected these results. The instability is treated in another section in this
chapter. Contrary to the mismatch experiments only the intensity differ-
ence between two samples is important. These are the one with the target
and the one without, that were measured in quick succession. 1 This is
why there is no instability expected during the AON-testing sessions.
1within 5 minutes
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The spectra from AON4 and AON5 without target show a very low inten-
sity since a fairly homogeneous distribution of configurations is formed
when the 19b-probe stabilises fluorescent clusters. The measurement is
tailored to this expected probe signal. The measured signals without the
target are thus mostly the background from a small number of 19b-probe
encapsulations forming naturally, which is slightly shifted by other con-
tributions. There still could be a dominant fluorescent source present in
these samples, but the corresponding peak would be outside our mea-
sured wavelength domain, see Theory 2.4.
5.2.3 Possibilities for application in mismatch studies
That AON1 to AON3 cannot be used is not problematic in the context of
medical applications since there are many AON-designs possible, far more
than treated in this thesis. When generalising the conclusion from this
experiment, the location dependent mismatch sensitivity of 2/5 of AONs
can be found using the AON-probe technique. This is still sufficient to
provide insight into binding behaviour that can significantly contribute to
AON development for exon skipping. Even so, optimising the procedure
could allow us to apply the probe technique to the other AONs potentially
as well.
5.3 Mismatch experiment
5.3.1 Normalisation and AON choice
The AON-testing results provide two suitable candidates for the mismatch
experiment: AON4 and AON5. In a previous study, an AON with 23 bases
was used [56]. AON4 has 20 bases without the probe, while AON5 also
has 23. AON4 is shorter than what has been studied already, thus using
it in our research provides a new insight into the binding behaviour of
shorter AONs. Furthermore, in medical applications, shorter AONs are
more commonly used, since long strands will bind frequently to a non-
target area, which should be prevented. The first strategy is to normalise
by intensity from the maximum efficiency, corresponding to the comple-
mentary strand. This way, we use the binding efficiency of a fully com-
plementary AON to quantify an ’efficiency’ of 1 and measure the binding
efficiencies of the mismatched strands, which should be lower, relative to
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this number.
However, it was found that the intensity from mismatches at terminals
was often higher and the intensity from the complementary was consid-
ered insufficiently precise to guarantee its accuracy, based on intermediate
results. It was therefore not used to normalise the results.
Instead, the intensity from mismatch position 20 was chosen as normali-
sation for the final result and all sessions in which it was measured. This
choice is based on the experience from previous studies that the binding
efficiency related ratio at the ends is closest to 1. In these studies, the re-
sult is normalised by the complementary strand. When position 20 was
not measured during a session, position 19 was used. This is considered
to be the second best option for normalisation since it is also close to the 3’
end. Position 1 or 2 was not chosen for the reason that the result close to
and at the 5’ end is less accurate because of the proximity of the mismatch
to the fluorescent silver cluster.
5.3.2 The experimental result
The overall shape of the experimental result in figure 4.3 suggests that the
AON containing a single mismatch binds most efficiently when this mis-
match is located at either end of the strand. It decreases further towards
the middle where it ”oscillates” about 0.6. This is plausible since a similar
result has been found in a study on surface bound DNA [15]. Especially
that the end positions correspond to a high efficiency is well in accordance
with studies that explicitly aim at the location dependency [13, 15, 53, 56].
The result from positions 14 and 16 may pose problems since binding effi-
ciency 1.0 lies within their error bars. Hence an unexpectedly high binding
efficiency, thus a low mismatch sensitivity for binding, cannot be excluded
and further experiments are be required to have an accurate measurement
of these points. Furthermore, the result at location 19 is above 1.0. This
point, however, can be considered to be particularly inaccurate as the cor-
responding error bar is far larger than that of the normalisation value at
position 20, for example. If the results are improved with future experi-
ments, this point is expected to be below 1.0. Additionally, the error bar
at position 2 does not even include values below 1. This can be expected
because of the proximity of the mismatch to the 19b-probe encapsulating
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the silver cluster, which can lead to an increase in intensity that does not
correspond to the binding efficiency. For this reason, the result at position
1, which would be even less accurate, is not processed for this result. Ad-
ditionally, the model cannot calculate the ratio for this mismatch location
either, as explained in Theory 2.3.3.
The errors in this result are significant and the dominant cause is assumed
to be the instability of the measurement, which is the undesired time-
dependency of the intensity. This means that the order of measuring the
samples influences the obtained intensity. To prevent the deforming of the
result, the order has been randomised from the third measurement ses-
sion onwards as mentioned in the Methods 3.3. This does not reduce the
spread in intensity results, however. It is expected that solving the instabil-
ity problem will greatly improve the accuracy and precision of the method.
The instability is considered to be the dominant factor because the human
error is moderate, see section 5.5 and the device’ measurement was pre-
cise. Leaving a sample in the fluorimeter and measuring again within a
minute leads to an overlapping spectrum, which indicates its consistency.
If the spread is still large in future results, it is recommended to obtain
more measurements to limit the effect of outliers. This will improve the
accuracy, which is especially required for mismatch positions 1, 2, 14, 16
and 19 and the complementary AON.
5.3.3 The model calculations
The model predicts the effect of a mismatch on the binding efficiency nor-
malised by that of the complementary strand. The probe-AON method
should relate this effect on binding efficiency directly to the relative fluo-
rescence intensity from the samples, in order to compare the model with
the experimental result meaningfully. As discussed in section 5.3.2, the
measured results for certain points, in particular, are considered to be in-
accurate, thus the validity of the model cannot be evaluated based on those
points.
The model uses separate terms corresponding to the left and right side of
the mismatch, thus the effect at end position 20 and 1 cannot be calculated,
which explains the absence of this point.
In the middle range, especially from position 7 to 14, the model is physi-
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cally plausible since the points lie within the error bars of the experimen-
tal result. At some of these points, the difference is still significant: up to
roughly 0.25. This difference seems to be proportional to the error leading
to the author’s hypothesis that the model is more accurate than the exper-
iment in this range.
Close to the edges, we observe a notable difference between model-generated
points and experimental ones. Due to the instability of the fluorescence,
the author of this thesis does not exclude systematic errors causing this
difference. Nevertheless, a previous study using the same method ob-
tained similar results, where the experimental result is far below the model
curve close to the edges, while these measurements were stable. Further-
more, nothing indicated that a structural error not related to instability has
caused this difference and it is therefore considered to be a model inaccu-
racy.
An explanation of this deviation is the effect of dangling ends that is lin-
ear with the length of the dangling sections in this model. In reality, the
effect increases rapidly with this length, thus the binding efficiency drops
rapidly as well, with the mismatch 2 positions from the 3’ or 5’ end on-
wards, in both studies.
5.4 Stability of intensity measurement
5.4.1 Observations and hypothesis
From fig 4.4 in the Results one can conclude that the intensity is stable for
the probe after approximately 20 minutes.Therefore, the mismatch mea-
surements obtained later were expected to be stable. This is substantiated
by the experience from the probe-AON strands in a previous study[56].
Based on all previous experience with fluorescent Ag-DNA, the inten-
sity of all samples should level exponentially, just like the result from the
probe. Because, in the result when the mismatch is located at position
14, the signal evolution initially has an increasing derivative, fitting the
behaviour with a single exponential would be impossible. It should be
possible to fit a single exponential to only the second half of this curve but
this would lead to an arbitrary interpretation of the development which
would be problematic as well. Applying the fit to the complementary
AON strand does indicate the expected time dependency during stabil-
isation.
Version of July 20, 2017– Created July 20, 2017 - 18:18
38
5.4 Stability of intensity measurement 39
The assumption that the evolution of the signal over time follows a single
exponential function is based on being able to approximate the formation
of a fluorescent cluster as a first order chemical reaction. This should be
the case when the only occurring process is the formation of fluorescent
clusters from the available silver atoms and ions. This is only the case,
however, if the other reactions, the reduction of the silver ions into atoms,
and the binding of the silver ions to the DNA strands, have completed
fully. The differences in the measured behaviour, especially in the early
stages of the measurement, indicate that these reactions do not complete
at the same rate for all samples, causing differences in their emission over
time.
Both strands’ intensities were not constant at the end of the stability mea-
surements as deduced from the slope at the last point. This means that
the intensity was not stable during the measurements of the mismatched
samples that started just after the stability measurement. The time devel-
opment was not monitored during these experiments, thus it is not known
in that period. Although the intensity could have become constant for sev-
eral minutes at some point, the instability at the start still has a significant
impact on the result. It is also plausible that, before the last sample was
put in the fluorimeter, the intensity had already started to decrease, lead-
ing to an even greater difference in intensity between samples.
Since the method relies on time independence of the emission throughout
the measurement this strongly suggests that the instability is a significant
factor influencing the mismatch experiment result.
5.4.2 Implications
The stability data was processed after the sessions, so this provides only a
hindsight check of stability, thus no corrections could be made to the ex-
periments. This problem could not be solved in the limited time available
for the BSc research and instead, the author chose to continue experiments
with the longer stabilising time of an hour to obtain an insightful result
nevertheless.
During the mismatch measurements, which were conducted right after
the stability measurement, the time development of each sample’s inten-
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sity is uncertain. From previous experience with fluorescent Ag-DNA, it
is known that the intensity decreases after several hours or earlier [56].
Therefore it is assumed for that from all samples in this research the emit-
ted intensity eventually falls as well.
From the results, the conclusion is drawn that the time between adding the
reductor and measuring the samples should be prolonged in future exper-
iments. Furthermore, the stability should be ensured before measuring
any other samples. Additionally, the time-dependent behaviour should
be studied over longer periods to evaluate its consistency. The purpose of
this is to properly schedule the measurement period in the interval that
the intensity is stable or to be able to correct for the time development of
the signal. If it is not consistent other measures should be taken to im-
prove the accuracy of the results, such as a simultaneous measurement of
a control-sample to be able to correct for instabilities or simply obtaining
far more measurement points.
5.5 Error involved in the preparation of the sam-
ples
Compared to the total error in the results, the error involved in the sample
preparation is relatively small: about 0.13. If this error is considered as
an independent addition, the total error is
√
σ2 + 0.132 in which σv is the
standard deviation due to other influences. Since the total error is above
0.20 for most points, the contribution of the preparation error is small. Let
us, for example, take σv as 0.3, then the total error will be
√
0.32 + 0.132 ≈
0.33, while it would be just 0.3 if the preparation error was absent. There-
fore the total error increases by only 0.03, which indicates an insignificant
impact. One can deduce or determine by filing in higher values for σv that
the contribution decreases for increasing σv (or total error). That said, the
measurement puts a minimum on the error in the used Ag-DNA probe
method of 0.13 if no other effects were present. This number is compara-
ble to the error observed in previous measurements on a different AON
[56].
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Conclusion
The developments to treat Duchenne muscular dystrophy are advancing.
A cure, however, is not expected to be found in the near future. An ap-
proach called ”exon skipping” uses molecules that bind to specific sites in
the genetic material to slow the progression of this impactful disease. This
is not safe when the drug components alter the expression of ”healthy”
parts of the genetic code as well. An optimal exclusivity of the binding is
required to prevent this. This can only be achieved with a substantially
improved understanding of the binding behaviour of nucleotide strands,
i.e. organic RNA and DNA in the context of this thesis.
An important factor is the presence of mismatches, i.e. defects that inhibit
the formation of base pairs. In particular, the location of such a mismatch
in a base sequence has a significant effect on binding efficiency, thus a
novel model has been developed for this purpose.
To evaluate this model, an experimental result is required under phys-
iological conditions in which the location dependency is isolated from
other factors. This BSc research provides this experiment and compares
the model to the obtained result. It uses a silver nanocluster encapsulated
in a DNA probe to relate the emission from the silver to the binding effi-
ciency.
Both the experimental result and the model calculation are deemed physi-
cally plausible and in accordance with each other for most of the mismatch
positions. The similarity to results from other studies is clear, which con-
tributes to this conclusion. However, the methodological differences be-
tween those studies and this BSc research are likely to cause the result to
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be different as well.
Although the found relation is considered to be generally valid, we ob-
serve some significant inaccuracies, in particular when the mismatch is
close to the ends of the strands. Depending on future results, the model
may need to include additional parameters to find better agreement with
the experimental data in these positions.
Additionally, the error in the measurement was substantial. This is proba-
bly caused by the instability of the fluorescence of the probe. Furthermore,
the sensitivity of the technique is dependent on the mismatch position rel-
ative to the probe. Therefore, in the future, further care must be taken in
ensuring the stability of the fluorescence during measurement, and in po-
sitioning the probe on either end of the AON strand.
Despite this, the probe technique itself provides a promising approach for
measuring the binding efficiency of nucleotide strands due to its simplic-
ity, low cost, short duration of the experiment and high resource availabil-
ity.
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Appendix
8.1 Acronyms and definitions
19b-probe Ag-DNA probe with a clear fluorescence spectrum which is
added to other strands to link emitted intensity to binding efficiency.
A Adenine, see ”Nucleotide”
AON ”Antisense oligonucleotide. Small pieces of DNA or RNA that can
bind to specific molecules of RNA. This blocks the ability of the
RNA to make a protein or work in other ways. Antisense oligonu-
cleotides may be used to block the production of proteins needed for
cell growth. They are being studied in the treatment of several types
of cancer. Also called antisense agent.” [82]
Base See ”Nucleotide”.
BMD Becker Muscular Dystrophy. A muscular dystrophy similar to DMD,
however less severe. exon skipping treatments can achieve the DMD
to be effectively BMD in patients.
C Cytosine, see ”Nucleotide”.
Complementary Able to form a perfectly matching double-stranded struc-
ture with the opposite nucleotide strand.
DMD ”Duchenne muscular dystrophy: The best-known form of muscu-
lar dystrophy, due to mutation in a gene on the X chromosome that
prevents the production of dystrophin, a normal protein in muscle.”[83]
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DNA Abbreviation of deoxyribonucleic acid. A double-stranded nucleic
acid that contains the genetic information for cell growth, division,
and function. [84]
DNA/DNA See ”X/Y”
Duplex ”Duplex DNA is another name for double-stranded DNA. This
means that the nucleotides of two DNA sequences have bonded to-
gether and then coiled to form a double helix. This double-stranded
structure facilitates the stable duplication of genetic material, a re-
quirement for cell division.”[85]
Dystrophin ”A protein located mainly in the heart and skeletal muscles
involved in strengthening of muscle fibers preventing from injury
as muscle contract and relax. Dystrophin gene is mapped on chro-
mosome Xp21.2 containing 86 exons that span at about 2,300kb with
3026-3345 amino acids having ZZ domain which is responsible for
Duchenne and Becker muscular dystrophies. Dystrophin serves as
an anchor that connects each muscle cells framework which plays
an important role in signaling through interacting with proteins that
send and receive chemical signals. It is expressed at higher level in
neuronal cells than astroglial cells in adult brain in which overex-
pression of this protein prevents the growth of abnormal mechanical
properties linked with dystrophic muscle.” [84]
Exon ”Genes contain exons which are regions coding for proteins and
which are interrupted by the unused sequences called introns. Ex-
ons have been found to include both sequences coding for amino
acids and untranslated sequences. The introns are removed and the
exons are joined together to form the final functional mRNA.”[84]
Exon skipping The a treatment currently in development for Duchenne
muscular dystrophy (DMD), where AONs are used to allow the syn-
thesis of partly functional dystrophin proteins instead of non-functional
ones. [86]
G Guanine, see ”Nucleotide”
Hybridisation The binding of single strands to opposite strands to form
a double stranded complex (a duplex). This occurs at a sufficiently
low temperature.
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Hydrogen bond The hydrogen bond is really a special case of dipole forces.
A hydrogen bond is the attractive force between the hydrogen at-
tached to an electronegative atom of one molecule and an electroneg-
ative atom of a different molecule. Usually the electronegative atom
is oxygen, nitrogen, or fluorine, which has a partial negative charge.
The hydrogen then has the partial positive charge.[29]
Intron See ”Exon”.
Melting temperature (TM) ”That temperature at which, under a given
set of conditions, double-stranded dNA is changed (50%) to single-
stranded DNA; under standard conditions, the base composition of
the DNA can be estimated from the denaturation temperature, since
the greater the denaturation temperature, the greater the guanine-
plus-cytosine content (i.e., GC content) of the DNA. ”[84]
Mismatch A defect in a nucleotide strand with an obnormal hydrogen
bond pattern inhibiting the formation of a base pair, e.g. a guanine
opposite of a thymine base.
mRNA ”Messenger RNA (mRNA) is a subtype of RNA. An mRNA molecule
carries a portion of the DNA code to other parts of the cell for pro-
cessing. mRNA is created during transcription. During the tran-
scription process, a single strand of DNA is decoded by RNA poly-
merase, and mRNA is synthesized. Physically, mRNA is a strand of
nucleotides known as ribonucleic acid, and is single-stranded. ”[87]
Nearest-Neighbour (NN) model A model to calculate the binding en-
ergy of a strand by using sequence dependent parameters, one for
each nucleobase and its adjacent base. The traditional version of this
model can only be applied to perfectly matching strands and that is
the only well established one.
NN See ”Nearest-Neighbour model”
(Nucleo)base Coding component of nucleotide strands that form hydro-
gen bonds with opposite bases, forming a base pair. The common
types are A, G, C and T (or U), mentioned in the definition of ”Nu-
cleotide”.
Nucleotide ”The basic building block of nucleic acids, such as DNA and
RNA. It is an organic compound made up of nitrogenous base, a
sugar, and a phosphate group. DNA molecule consists of nucleotides
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in which the sugar component is deoxyribose whereas the RNA molecule
has nucleotides in which the sugar is a ribose. The most common
nucleotides are divided into purines and pyrimidines based on the
structure of the nitrogenous base. In DNA, the purine bases include
adenine and guanine while the pyrimidine bases are thymine and cy-
tosine. RNA includes adenine, guanine, cytosine, and uracil in stead
of thymine (thymine is produced by adding a methyl to uracil).”[84]
Pre-mRNA ”An immature or incompletely processed mRNA molecule in
eukaryotes originated from primary transcript (hnRNA) in the nu-
cleus and need to be processed before it becomes a fully functional
mature mRNA for transport into the cytoplasm.” [84]
Purines See ”Nucleotide”
Pyrimidines See ”Nucleotide”
RNA ”Ribonucleic acid (RNA) is a linear molecule composed of four types
of smaller molecules called ribonucleotide bases: adenine (A), cy-
tosine (C), guanine (G), and uracil (U). RNA is often compared to
a copy from a reference book, or a template, because it carries the
same information as its DNA template but is not used for long-term
storage.”[87]
Splicing ”Removal of introns and connecting of exons in eukaryotic pre-
mRNAs to form the mRNA.”[87]
T Thymine, see ”Nucleotide”
X/Y The slash means in biological context ”Nucleotide strand X bound to
the opposite strand Y”, for example DNA/RNA, or AON/Exon
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8.2 Used DNA sequences
8.2.1 Variable sequences
Name Sequence
TestAON1 TGCCTTTTGGGGACGGATACCTCTGTGATTTTATAACTT
TestAON2 TGCCTTTTGGGGACGGATACCCACCATCACCCTCTGTGA
TestAON3 TGCCTTTTGGGGACGGATACCCACCATCACCCTCTGTGATTT
TestAON4 TGCCTTTTGGGGACGGATAGGTCACCCACCATCACCCTC
TestAON5 TGCCTTTTGGGGACGGATACCTCAAGGTCACCCACCATCACC
TestAON4-MM1 TGCCTTTTGGGGACGGATATGTCACCCACCATCACCCTC
TestAON4-MM2 TGCCTTTTGGGGACGGATAGTTCACCCACCATCACCCTC
TestAON4-MM3 TGCCTTTTGGGGACGGATAGGACACCCACCATCACCCTC
TestAON4-MM4 TGCCTTTTGGGGACGGATAGGTTACCCACCATCACCCTC
TestAON4-MM5 TGCCTTTTGGGGACGGATAGGTCTCCCACCATCACCCTC
TestAON4-MM6 TGCCTTTTGGGGACGGATAGGTCATCCACCATCACCCTC
TestAON4-MM7 TGCCTTTTGGGGACGGATAGGTCACTCACCATCACCCTC
TestAON4-MM8 TGCCTTTTGGGGACGGATAGGTCACCTACCATCACCCTC
TestAON4-MM9 TGCCTTTTGGGGACGGATAGGTCACCCTCCATCACCCTC
TestAON4-MM10 TGCCTTTTGGGGACGGATAGGTCACCCATCATCACCCTC
TestAON4-MM11 TGCCTTTTGGGGACGGATAGGTCACCCACTATCACCCTC
TestAON4-MM12 TGCCTTTTGGGGACGGATAGGTCACCCACCTTCACCCTC
TestAON4-MM13 TGCCTTTTGGGGACGGATAGGTCACCCACCAACACCCTC
TestAON4-MM14 TGCCTTTTGGGGACGGATAGGTCACCCACCATTACCCTC
TestAON4-MM15 TGCCTTTTGGGGACGGATAGGTCACCCACCATCTCCCTC
TestAON4-MM16 TGCCTTTTGGGGACGGATAGGTCACCCACCATCATCCTC
TestAON4-MM17 TGCCTTTTGGGGACGGATAGGTCACCCACCATCACTCTC
TestAON4-MM18 TGCCTTTTGGGGACGGATAGGTCACCCACCATCACCTTC
TestAON4-MM19 TGCCTTTTGGGGACGGATAGGTCACCCACCATCACCCAC
TestAON4-MM20 TGCCTTTTGGGGACGGATAGGTCACCCACCATCACCCTT
8.2.2 Target sequence
Exon51-loc28-29: TGGCTTTCTCTGCTTGATCAAGTTATAAAATCACA-
GAGGGTGATGGTGGGTGACCTTGAGGATATCAACGAGATGATCATCAAGCAGAAG
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8.3 Recipe for AON-testing experiment
1. Insert 60 µl of the 25 mM HEPES-NaOH pH 7.4 buffer into the 1.5 ml
tube.
2. Add 20 µl of the 100 µM Exon DNA solution for the bound configura-
tion or 20 µl nuclease-free water for the unbound configuration.
3. Add 20 µl of the 100 µM AON DNA solution. After this step the tubes
are centrifuged for 10 seconds at 10,000 rpm to mix their contents properly
and to avoid droplets on the walls1.
4. Keep all tubes at 37 ◦C for two hours.
5. Add 10 µl of the 1.92 mM AgNO3 solution.
6. Keep all tubes at 37 ◦C in the dark for 30 minutes and prepare a NaBH4
solution of 0.96 mM.
7. Add 10 µl 0.96 mM NaBH4 solution.
1This measure was only taken during some of the mismatch experiments described in
section Mismatch experiment.
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